Evidence map›Paper›PMID 28325997›Full record

ReviewGerman medical science : GMS e-journal2017

A comprehensive approach in high-grade glioma management: position statement from the Neuro-Oncology Scientific Club (NOSC), Shiraz, Iran.

Mansour Ansari, Ahmad Mosalaei, Niloufar Ahmadloo, Alireza Rasekhi, Bita Geramizadeh, Ali Razmkon, Kazem Anvari, Mohammad Afarid, Ali Dadras, Leila Nafarieh and 5 more

Abstract readReviewConsensus Statement
PubMed Full text at PMC Publisher
In one paragraph

Review in German medical science : GMS e-journal, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors.

Mansour AnsariDepartment of Radiation Oncology, School of Medicine, Shiraz University of Medical Sciences, Shiraz, Iran.
Ahmad MosalaeiDepartment of Radiation Oncology, School of Medicine, Shiraz University of Medical Sciences, Shiraz, Iran.
Niloufar AhmadlooDepartment of Radiation Oncology, School of Medicine, Shiraz University of Medical Sciences, Shiraz, Iran.
Alireza RasekhiDepartment of Radiology, School of Medicine, Shiraz University of Medical Sciences, Shiraz, Iran.
Bita GeramizadehDepartment of Pathology, School of Medicine, Shiraz University of Medical Sciences, Shiraz, Iran.
Ali RazmkonDepartment of Neurosurgery, School of Medicine, Shiraz University of Medical Sciences, Shiraz, Iran.
Kazem AnvariCancer Research Center, Mashhad University of Medical Sciences, Mashhad, Iran.
Mohammad AfaridBehestan Medical Scientific Committee, Behestan Group, Tehran, Iran.
Ali DadrasBehestan Medical Scientific Committee, Behestan Group, Tehran, Iran; Institute of Biochemistry and Biophysics (IBB), University of Tehran, Tehran, Iran.
Leila NafariehBehestan Medical Scientific Committee, Behestan Group, Tehran, Iran.
Mohammad MohammadianpanahDepartment of Radiation Oncology, School of Medicine, Shiraz University of Medical Sciences, Shiraz, Iran.
Hamid NasrolahiDepartment of Radiation Oncology, School of Medicine, Shiraz University of Medical Sciences, Shiraz, Iran.
Seyed Hasan HamediDepartment of Radiation Oncology, School of Medicine, Shiraz University of Medical Sciences, Shiraz, Iran.
Shapour OmidvariDepartment of Radiation Oncology, School of Medicine, Shiraz University of Medical Sciences, Shiraz, Iran.
Mohammad NamiBehestan Medical Scientific Committee, Behestan Group, Tehran, Iran; Department of Neuroscience, School of Advanced Medical Sciences and Technologies, Shiraz University of Medical Sciences, Shiraz, Iran; Neuroscience Laboratory (Brain, Cognition and Behavior), Department of Neuroscience, School of Advanced Medical Sciences and Technologies, Shiraz University of Medical Sciences, Shiraz, Iran; Shiraz Neuroscience Research Center, Shiraz University of Medical Sciences, Shiraz, Iran.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Establishing a robust teamwork model in the practice of neuro-oncology requires continued interdisciplinary efforts. The Neuro-Oncology Scientific Club (NOSC) initiative is an interdisciplinary clinical forum promoting the comprehensive approach across involved disciplines in the management of central nervous system (CNS) malignancies. With its provincial founding panels and national steering board, NOSC has been operational in Iran since 2011. This initiative has pursued its mission through interval strategic meetings, tumor boards, case discussions as well as publishing neuro-oncology updates, case study periodicals, and newsletters. A provincial meeting of NOSC in Shiraz put together insights from international practice guidelines, emerging evidence, and expert opinions to draw a position statement on high-grade glioma management in adults. The present report summarizes key highlights from the above clinical forum.

Indexed as

Patient Care TeamAdultBrain NeoplasmsCombined Modality TherapyCritical PathwaysGliomaHumansIranMagnetic Resonance ImagingMedical OncologyNeuroimaginghigh-grade gliomainterdisciplinaryneuro-oncologyposition statementShiraz

Identifiers

PMID28325997
PMCPMC5332812

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.